Etiology and outcomes: Thrombotic microangiopathies in pregnancy. [PDF]
Scully M, Neave L.
europepmc +2 more sources
Etiology and Outcomes of Thrombotic Microangiopathies.
BACKGROUND AND OBJECTIVES Thrombotic microangiopathies constitute a diagnostic and therapeutic challenge. Secondary thrombotic microangiopathies are less characterized than primary thrombotic microangiopathies (thrombotic thrombocytopenic purpura and ...
Bayer G +21 more
europepmc +2 more sources
Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review [PDF]
Complement-mediated thrombotic microangiopathies (CM-TMA) are rare and life-threatening disorders characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
Pilar Musalem
doaj +2 more sources
Complement Activation and Thrombotic Microangiopathies.
BACKGROUND AND OBJECTIVES Atypical hemolytic uremic syndrome is a form of thrombotic microangiopathy caused by dysregulation of the alternative complement pathway. There is evidence showing complement activation in other thrombotic microangiopathies. The
Palomo M +36 more
europepmc +2 more sources
Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics. [PDF]
Thrombotic microangiopathies (TMAs) are a heterogeneous group of syndromes presenting with a distinct clinical triad: microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
Gavriilaki E +2 more
europepmc +2 more sources
An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy. [PDF]
Conditions presenting with signs of thrombotic microangiopathies (TMAs) comprise a wide spectrum of different diseases. While pathological hallmarks are thrombosis of arterioles and capillaries, clinical signs are mechanical haemolysis, thrombocytopenia ...
Aigner C +3 more
europepmc +2 more sources
Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus. [PDF]
Antiphospholipid syndrome (APS) and other causes of thrombotic microangiopathy (TMA) negatively impact the renal outcomes of patients with systemic lupus erythematosus (SLE) and lupus nephritis.
Kotzen ES, Roy S, Jain K.
europepmc +2 more sources
Influenza-associated thrombotic microangiopathies. [PDF]
Thrombotic microangiopathy (TMA) refers to phenotypically similar disorders, including hemolytic uremic syndromes (HUS) and thrombotic thrombocytopenic purpura (TTP). This review explores the role of the influenza virus as trigger of HUS or TTP.
Bitzan M, Zieg J.
europepmc +2 more sources
Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances [PDF]
Robert W. Maitta +3 more
doaj +2 more sources
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies [PDF]
Marie Scully +7 more
openalex +2 more sources

